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Abstract
AIM: To study the effects of live and dead Lactobacillus 
rhamnosus  GG (GG) on rotavirus infection in a neonatal 
rat model.
METHODS: At the age of 2 d, suckling Lewis rat pups 
were supplemented with either live or dead GG and the 
treatment was continued daily throughout the experi-
ment. At the age of 5 and 6 d the pups received oral 
rotavirus (RV) SA-11 strain. The pups were sacrificed at 
the age of 7 or 8 d by decapitation. The gastrointestinal 
tract was removed and macroscopic observations were 
done. The consistency of feces in the colon was classi-
fied using a four-tier system. RV was detected from the 
plasma, small intestine, colon and feces by real-time 
quantitative polymerase chain reaction (PCR).
RESULTS: In this neonatal rat model, RV induced a 
mild-to-moderate diarrhea in all except one pup of the 
RV-inoculated rats. RV moderately reduced body weight 
development from day 6 onwards. On day 7, after 2 d 
of RV infection, live and dead GG groups gained signifi-
cantly more weight than the RV group without probiot-
ics [36% (P  = 0.001) and 28% (P  = 0.031), respec-
tively]. In addition, when compared with the RV control 
group, both live and dead GG reduced the weight ratio 
of colon/animal body weight to the same level as in 
the healthy control group, with reductions of 22% (P 
= 0.002) and 28% (P  < 0.001), respectively. Diarrhea 
increased moderately in both GG groups. However, the 
diarrhea incidence and severity in the GG groups were 
not statistically significantly different as compared with 
the RV control group. Moreover, observed diarrhea did 
not provoke weight loss or death. The RV control group 
had the largest amount of RV PCR-positive samples 
among the RV-infected groups, and the live GG group 
had the smallest amount. Rats receiving live GG had 
significantly less RV in the colon (P  = 0.027) when 
compared with the RV control group. Live GG was also 
more effective over dead GG in reducing the quantity of 
RV from plasma (P  = 0.047). 
CONCLUSION: Both live and dead GG have beneficial 
effects in RV infection. GG may increase RV clearance 
from the body and reduce colon swelling. 
© 2012 Baishideng. All rights reserved.
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INTRODUCTION
Group A rotaviruses are the leading cause of  acute ga­
stroenteritis in children < 2 years of  age and account 
annually for nearly 600  000 child deaths worldwide[1]. 
Rotavirus­induced diarrhea causes severe dehydration 
and vomiting which can be fatal for malnourished babies. 
In developed countries rotavirus gastroenteritis causes a 
large economic burden with a substantial number of  hos­
pitalizations, doctoral visits, and medical costs. Two vac­
cines are available to prevent RV infection, but their use 
may be limited by financial constraints especially in low-
income countries. 
The use of  probiotic bacteria has gained consider­
able attention as a safe and accessible form of  treatment 
for gastrointestinal diseases[2,3]. Lactobacillus rhamnosus GG 
(GG), in particular, has been effective in reducing both 
duration[3­6], and severity[6,7] of  rotavirus­induced diarrhea. 
The therapeutic capacity of  GG against rotavirus gastro­
enteritis might be due to its ability to adhere to intestinal 
epithelial cells and compete for binding with the patho­
gens[8,9], or displace bound pathogens[10], stabilize and 
reinforce the mucosal barrier[11­13], and stimulate the local 
antigen specific and nonspecific immune responses[5,12,14]. 
However, the effect mechanisms of  GG in rotavirus di­
arrhea are not completely understood.
Only a few studies have addressed the effects of  inac­
tivated probiotics in rotavirus diarrhea[5,15]. When study­
ing the effects of  inactivated and live GG on acute RV 
diarrhea in children, both product forms equally pro­
moted clinical recovery from diarrhea, but only live GG 
enhanced an IgA antibody response to RV[5]. In mice, in 
contrast to live GG, heat­killed GG failed to protect ani­
mals from duration or severity of  RV diarrhea[15]. How­
ever, these studies did not include an untreated control 
group to allow comparison between the effects of  prod­
uct forms and RV.
In order to gain more understanding of  the effect 
mechanisms of  live and dead GG in RV­induced diar­
rhea, we compared their effects in the suckling rat RV 
SA­11 infection model with regard to parameters of  
infection severity such as weight gain, colon weight, con­
sistency of  the feces, and also measured the amount of  
rotavirus in plasma, intestine, and feces. 
MATERIALS AND METHODS
Animals 
This study was approved by the Animal Care and Use 
Committee of  the State Provincial Office of  Southern 
Finland (license number ESAVI­2010­06221_Ym­23). 
Pregnant­specific pathogen­free Lewis rats were ob­
tained from Harlan (Horst, The Netherlands) and they 
were allowed to give birth naturally in the test facility. 
The birth time of  the pups was monitored twice a day. 
All pups were born on the same day within 12 h. Prior 
to all experiments, each litter was adjusted to 6 pups per 
dam to avoid biological variation due to litter size. The 
litters were randomly assigned to 4 experimental groups 
(4 dams with 6 pups each, n = 24): rats infected with RV 
SA­11 alone (RV control group); dead GG treated + RV 
SA­11 infected rats (dead GG group); live GG treated + 
RV SA­11 infected rats (live GG group); and minimum 
essential medium (MEM) control animals (healthy control 
group). The rat pups remained with their dams through­
out the study. Control and inoculated groups were 
housed in the same individually ventilated Scantainer 
(Scanburg, Denmark), and each RV­infected group in its 
own Scantainer, in a normal rat cage (Makrolon Ⅲ) with 
Aspen chips bedding (Tapvei Oy, Kaavi, Finland) and 
nest material (Aspen chips PM90L/R). The temperature 
was 22 ± 2 ℃ with relative humidity 50%­95%. Lighting 
was artificial, 12 h light and 12 h dark (18:00-06:00). Food 
(TEKLAD T.2916 IRR*; Irradiated Global 16%, Rodent 
Diet for mice and rats, Harlan) and deionized water were 
autoclaved and provided ad libitum from the day of  the 
rats arrival until the completion of  the experiments. The 
animals were identified individually by dorsal numbering.
Lactobacillus rhamnosus GG products 
Viability was determined by plating the GG prepara­
tion after inactivation and no colony forming units (cfu) 
were detected. Both live and dead GG (ATCC 53103) 
were obtained from Valio (Valio Ltd, Helsinki, Finland). 
Prior use live GG stock (1011 cfu/mL) was aliquoted in 
de Man, Rogosa and Sharpe culture medium broth and 
stored at ­20 ℃. Powdered dead GG (killed at Valio Ltd, 
trade secret) at an equivalent cfu number of  1011 cfu/g of  
viable GG was maintained at room temperature. For the 
experiments live GG was thawed and dead GG weighed, 
and both were prepared daily in PBS at a concentration 
of  3 × 109cfu/mL.
Virus propagation
Simian RV SA­11 strain was grown in a continuous 
cell line of  rhesus monkey kidney cells, MA­104. The 
cells were cultivated in MEM containing 10% heat­
inactivated fetal bovine serum supplemented with 2 
mmol L­glutamine, penicillin and streptomycin in roller 
flasks in roller apparatus at 37 ℃. When the cells had a 
5926 November 7, 2012|Volume 18|Issue 41|WJG|www.wjgnet.com
Ventola H et al . Lactobacillus rhamnosus  GG in rotavirus infection
confluency of  70%­80%, they were inoculated from a 
stock containing 108 pfu/mL of  plaque­purified rota­
viruses. Before inoculation, RV stock was treated with 
10­20 μg/mL (final concentration) of  trypsin (Sigma, 
St Louis, United States) for 30 min at 37 ℃. RV stock 
in dilution 10­4 was added to each roller bottle. After 
incubation for 1 h, 30 mL of  serum­free MEM with 
1 μg/mL of  trypsin was added, and the cultivation 
was continued for 48 h at 37 ℃. RV were harvested 
by freeze­thawing of  cells for 3 times, cell debris was 
removed by low­speed centrifugation, supernatant was 
collected, divided into aliquots, and stored at ­70 ℃ until 
use. RV titre was determined as 1.4 × 108 pfu/mL.
Animal experiments
The pups were weighed at fixed times daily before, and 
twice a day after, RV infection. At the age of  2 d, pups 
received a single daily 0.05 mL dose of  either dead or live 
GG supplementation (1.5 × 108 cfu/pup). RV SA­11 was 
inoculated by plastic feeding tube in 3 separate doses to 
achieve the total amount of  108 pfu/pup as follows: at 
the age of  5 d pups received 2 RV doses (0.3 mL each), 
and the third dose at the age of  6 d (0.12 mL) in order 
to boost the RV infection. MEM containing 100 × glu­
tamine, penicillin 100 IU/mL, streptomycin 100 μg/mL 
was used as a healthy control. After inoculations pups 
were returned to their dams and allowed to suckle. 
Clinical indices and specimen collection
The pups were randomized to be exsanguinated from 
either 2 d or 3 d post­infection at the age of  7 d and 8 
d. The blood samples were collected from all animals 
by decapitation into EDTA tubes (Venosafe™), and the 
plasma was obtained by centrifugation (10 min, 4000 
rpm), and frozen at ­20 ℃ within 1 h from sampling. 
The gastrointestinal tract was removed for macroscopic 
observations and specimen collection immediately af­
ter blood sampling. Small intestine was collected and 
weighed; colon tissue was collected and removed from 
its content by gently pushing along the tissue length by 
a spatula after which it was weighed. The feces were col­
lected by carefully emptying the colon and rectum. Speci­
mens were stored in dried ice until storing them at ­80 ℃. 
Consistency of  feces was classified from 0-3 using a four-
tier system: [0 = normal feces, 1 = slight diarrhea (feces 
is pale but solid); 2 = moderate diarrhea (feces is pale and 
semi­solid); 3 = strong diarrhea (feces is clearly wet)].
Sample processing
Plasma samples were thawed and viral RNA was extract­
ed from 0.1 mL of  sample with BioSprint® 96 One­For­
All Vet­kit (Qiagen GmbH, Hilden, Germany), using the 
automated KingFisher mL purification system (Thermo 
Fisher Scientific, Vantaa, Finland) according to the manu­
facturer’s instructions.
Frozen small intestine, colon, and feces were homog­
enized for nucleic acid extraction. Feces were processed 
on ice in 0.2 mL of  10% protease­inhibitor solution 
containing 1% bovine serum albumin, 10 mmol pefabloc 
(Roche Applied Science, Mannheim, Germany), 100 
μg/mL aprotinin (Sigma­Aldrich, St. Louis, MO, United 
States) 100 μg/mL leupeptin (Sigma­Aldrich) in Eagle 
minimum essential medium I (Gibco, Carlsbad, CA) 
supplemented with 5% fetal calf  serum, and 20 mmol 
Hepes (pH 7.4). Suspensions were vortexed with sterile 
glass beads, centrifuged (10 min, 5000 rpm), and viral 
RNA was extracted from supernatants with E.Z.N.A.® 
Total RNA Kit (Omega Bio­Tek, Doraville, GA, United 
States) according to manufacturer’s instructions. 
Colon and the entire small intestine with its contents 
were homogenized with sterile glass rods, and 30 mg of  
homogenized tissue was added into 0.6 mL of  RLT buf­
fer (Qiagen) and incubated at 37 ℃ for 10 min in a water 
bath. The lysate was centrifuged with QIAshredder (Qia­
gen) (2 min, 12  000 × g), and RNA was extracted with 
RNeasy Mini Kit (Qiagen) or BioSprint® 96 One­For­
All Vet­kit (Qiagen) using the automated KingFisher mL 
purification system as above.
Detection of rotavirus 
A total of  10 μL of  the viral RNA was reverse tran­
scribed into cDNA with the High­Capacity cDNA Re­
verse Transcription Kit (Applied Biosystems, Foster City, 
CA, United States) in a 20 μL reaction volume according 
to the manufacturer’s instructions. real­time (RT) reaction 
was performed as described with few modifications[16]. 
Depending on the sample material, RNA was first dena­
tured for 5 min at 95 ℃, and RT was performed by incu­
bating the reaction mixture for 10 min at 25 ℃, 120 min 
at 37 ℃, and 5 min at 85 ℃. The quantitative polymerase 
chain reaction (qPCR) protocol and the primers which 
target the VP7 gene of  RV were designed according to 
the primers described by Li et al[17]. Briefly, the qPCR re­
action was carried out in 25 μL reaction mixtures consist­
ing of  12.5 μL of  2 × SYBR Premix Ex Taq™ (Takara, 
Dalian, China), 0.5 μL of  each primer (20 μmol/L final 
concentrations), 0.5 μL ROX Ref  Dye II (50 ×), 4 μL of  
RV cDNA template, and 7 μL of  sterile water (Sigma­
Aldrich). The thermocycling profile included initial dena­
turation at 95 ℃ for 30 s, followed by 45 cycles of  95 ℃ 
for 5 s, 58 ℃ for 20 s, and 72 ℃ for 30 s. Finally, the 
melting curve analysis was performed at 95 ℃ for 1 min, 
55 ℃ for 30 s, and 95 ℃ for 30 s. RNA isolated from 
cultured RV SA­11 samples was used as a positive control 
to establish the standard curve, and sterile water (Sigma­
Aldrich) as a negative control. The samples were regarded 
RV SA­11 positive if  the melting peak temperature was 
83 ± 1.5 ℃. The results were analyzed by comparing the 
cycle threshold (CT) values, which were inversely corre­
lated with the amount of  RV VP7 gene in the sample, i.e., 
the lower the CT value, the greater the amount of  gene in 
sample.
Statistical analysis
Analysis of  variance was applied to compare the groups 
with respect to weight gain and colon weight, and the 
results are given as means with standard error of  the 
mean ± SE. In cases of  significant global P­values, 
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during the experiment. There were no significant dif­
ferences in body weight development before the virus 
inoculation between the study groups. RV moderately 
reduced body weight development from day 6 onwards 
(1 d after the infection) when compared with the pups 
receiving only MEM (Figure 1). RV did not severely com­
promise the condition of  the pups. One pup died from 
the healthy group due to technical difficulties in dosing. 
The groups pre­colonized with live or dead GG had 
gained significantly more weight on day 7 than the RV 
group without probiotics [36% (P = 0.001) and 28% (P = 
0.031), respectively]. 
Colon weight: Tissue samples were blindly collected and 
weighed at necropsy. In the large intestine, RV increased 
the weight of  colon. Results between groups were com­
pared by measuring the ratio of  colon weight/body 
weight (Figure 2). When compared with the RV control 
group, both live and dead GG reduced the weight ratio 
of  the colon to the same level as seen in the healthy con­
trol group, with reductions of  22% (P = 0.002) and 28% 
(P < 0.001), respectively.
Diarrhea: At the necropsy, diarrhea was determined in 
a blinded fashion by scoring the consistency of  feces us­
ing the four­tier system from 0­3. RV induced a mild­to­
moderate diarrhea in all except one of  the RV­inoculated 
rats when compared with the healthy control group. In 
live and dead GG groups, diarrhea seemed to be moder­
ately increased. However, the diarrhea incidence or sever­
ity in the groups was not statistically significant (P > 0.05) 
as compared with the RV control group (Table 1).
multiple comparisons were performed and the P­values 
were Bonferroni corrected. RV diarrhea occurrence and 
severity between the study groups were analyzed us­
ing logistic regression analysis. Statistical differences in 
the CT­values between RV­infected groups were ana­
lyzed using Kruskal­Wallis test (global test) and Mann­
Whitney U­test (pair­wise comparisons). P­values < 0.05 
were considered statistically significant. The data were 
analyzed using PASW version 18.0 (SPSS Inc. Chicago, 
IL, United States).
RESULTS
Clinical investigations 
Weight gain: The pups were weighed 1­2 times daily 
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Figure 1  Percentage weight gain of the rats. The rat pups were weighed 1-2 
times daily after day 2 during the experiment. On days 5 and 6, rotavirus (RV) 
was inoculated orally to the rats. Weight gain is expressed as percentual weight 
gain from the beginning of the experiment. aP < 0.05 vs RV control group; cP < 
0.05 vs dead GG group.
Table 1  Classification of diarrhea
Healthy control group 
(n  = 5)
RV control 
group (n  = 6)
Dead GG 
group (n  = 6)
Live GG group 
(n  = 6)
0 0 2 3
0 1 2 2
0 2 2 2
0 1 3 3
0 2 2 3
NA1 1 1 1
There was no statistically significant difference between groups. 1Animal 
deceased during the experiment due to technical error in dosing. RV: 
Rotavirus; NA: Not analyzed.
Table 2  Number of rotavirus polymerase chain reaction-
positive samples in the indicated test groups
Group RV PCR-positive samples
Plasma Small intestine Colon Feces
Healthy control group 0/5 0/5 0/5 0/5
RV control group 6/6 5/6 6/6 5/6
Dead GG group 6/6 4/6 6/6 4/6
Live GG group 6/6 2/6 6/6 3/6
Samples with cycle threshold (CT)-values < 45 were regarded as positive. 
RV: Rotavirus; PCR: Polymerase chain reaction.
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Figure 2  Weight of colon without feces. Results between groups are pre-
sented as the weight ratio of colon/animal. P = 0.002, P = 0.001, P < 0.001 vs 
rotavirus (RV) control. 
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Rotavirus detection 
The number of  RV PCR­positive samples in the study 
groups is shown in Table 2. In the healthy control group, 
RV was detected from none of  the samples. Overall, the 
RV control group had the largest amount of  RV PCR­
positive samples among the 3 groups, and live GG group 
the smallest amount. By comparing the CT values be­
tween the groups, we found that rats receiving live GG 
had significantly less RV VP7 gene in the colon (P = 
0.027) when compared with the RV control group (Figure 
3). Live GG was also more effective than dead GG in re­
ducing the quantity of  RV from plasma (P = 0.047). 
DISCUSSION
In the present study conducted in a neonatal rat model, 
we characterized the effects of  live and dead probiotic 
strain Lactobacillus rhamnosus GG on RV­induced diarrhea. 
We found that both groups receiving GG had smaller 
amounts of  RV in the intestinal tissues and feces over 
the RV control group. In particular, live GG was effec­
tive in reducing the number of  RV in the colon. Similar 
studies exist in mice, where live GG supplementation in 
combination with antibodies reduced rhesus RV load in 
the small intestine[15]. This increased RV clearance could 
be one of  the effect mechanisms of  GG in RV diarrhea, 
as it could shorten the duration of  disease, as seen in 
clinical studies[5,18,19]. Since RV is also capable of  spread­
ing systemically, and infecting extraintestinal tissues such 
as liver, kidney, and central nervous system[20­23], the other 
potentially beneficial effect mechanism of  GG against 
RV diarrhea might be its ability to inhibit the virus en­
tering the blood circulation. Here, live GG appeared to 
reduce the quantity of  RV in plasma. 
Similar to other studies, RV SA­11 was effective in 
inducing diarrhea in the rat pups[24,25]. Interestingly, we 
found that both live and dead GG seemed to slightly, 
though not significantly, increase diarrhea. Lactobacillus 
species in general seem to have an anti­diarrheal effect 
in clinical and in vivo studies[5,6,26,27]. Especially in neona­
tal rats, Lactobacillus casei (L. casei) DN­114 001 strain in 
fermented milk decreased clinical signs of  RV SA­11­
induced diarrhea, reduced the number of  RV antigens 
from the small intestine 48 h after infection, and reduced 
RV antigen load in the feces[24]. Our results may be ex­
plained by the fact that nitric oxide (NO), which may 
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Figure 3  Rotavirus detection in plasma, small intestine, colon, and feces by real-time quantitative polymerase chain reaction. Limit of detection of the reac-
tion was cycle threshold (CT) 45. The lines represent the mean of the CT-values. P = 0.047 vs RV control group, P = 0.027 vs dead GG group. 
P  = 0.047
P  = 0.027
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stimulate the enteric nervous system and induce water 
secretion into a luminal space further causing diarrhea[28], 
is released by RV­infected enterocytes[29], and GG also 
induces NO in macrophages[30]. Enhanced diarrhea in the 
GG groups may further lead to the increased clearance 
of  RV from the intestinal tissues by inhibiting adherence 
of  RV, and “flushing” the virus from the body. However, 
we did not include a group receiving only GG, and can­
not confirm whether the amount of  GG could have an 
effect on the consistency of  feces. On the other hand, 
another study did not report any changes in the feces in 
groups receiving probiotic supplements alone[24]. 
Although the pups suffered from diarrhea, both 
groups receiving either live or dead GG gained more 
weight than the RV control group after RV inoculation. 
However, another probiotic strain, L. casei DN­114 001, 
failed to induce weight gain in a similar RV SA­11 rat 
model[24], suggesting that the effect is strain specific. In­
terestingly, after day 6, the percentage weight gain was 
also reduced in the uninfected healthy control group. It is 
possible that a relatively large number of  dosings during 
a short period of  time partly inhibited rat pups to suckle 
milk from their dams. 
RV induces inflammation and promotes tissue swell­
ing by activating cytokine response of  intestinal epithelial 
cells[31]. RV­induced tissue swelling could this way increase 
weight of  the colon. Interestingly, we found that both live 
and dead GG reduced colon weight. In the GG group 
this reduction may result from the GG’s ability to stimu­
late the production of  anti­inflammatory cytokines[32]. 
These results further support the idea that GG might 
shorten the duration, and enhance the recovery from RV 
diarrhea.
The question of  whether unviable and killed bacte­
ria could have similar beneficial effects as live probiotic 
strains is contradicted. In clinical studies, heat­inactivated 
GG in children was unable to elicit local or systemic 
effects in rotavirus diarrhea[5]. In addition, a heat­inac­
tivated probiotic mixture including GG was ineffective 
against antibiotic­associated diarrhea when compared 
to equivalent live strains[33]. In children with milk allergy, 
heat­inactivated GG treatment was associated with diar­
rhea[34]. However, animal experiments conducted with 
unviable GG showed that the unviable form has ben­
eficial effects against several inflammatory conditions 
such as arthritis and Escherichia coli lipopolysaccharide­
induced inflammation in the lungs and liver of  rats[32,35]. 
This finding was possibly seen in our study as reduced 
colon weight. Nevertheless, live GG seemed to be more 
effective over dead GG in increasing the weight gain of  
rat pups after RV infection, and was more efficient in 
reducing the number of  RV from plasma. The effects of  
dead bacteria, however, might depend on the method of  
inactivation. For instance, inactivation by heat or irradia­
tion might disrupt the surface protein conformation of  
the bacteria, inhibiting the probiotic’s ability to adhere to 
epithelial cell[36]. In case the anti­diarrheal effects are due 
to secreted bioactive or antimicrobial peptides[13,36,37], GG 
needs to be viable. 
In conclusion, only live GG decreased the number of  
RV in the colon of  infected rat pups. However, dead GG 
had also some potential to alleviate RV infection pos­
sibly by reducing tissue swelling. The results provide new 
insights into aspects of  the bacterial strain’s viability, of­
fering new possibilities to develop novel functional food 
matrices.
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effects of both live and dead GG in RV infection in a neonatal rat model.
Innovations and breakthroughs
Recent clinical and animal studies have shown that GG relieves RV infection by 
shortening the duration of diarrhea, and reduces the amount of RV in intesti-
nal tissues. In the present study the authors found only live GG reduced the 
amount of RV in intestinal tissues. However, the dead product form was found 
to have a potential to decrease RV diarrhea-induced weight reduction, and in-
hibit RV-induced colon swelling. 
Applications
The results of this study indicate that the viable and dead forms of the bacte-
rium have different favorable effects on RV infection. Dead product forms would 
have a great potential in the food industry by providing new product applica-
tions, increasing product shelf life, and reducing storage costs. 
Terminology
Probiotic bacteria are defined as live microorganisms that have beneficial ef-
fects on human health. However, data regarding whether dead bacteria could 
have similar favorable health effects to live probiotic strains is limited.
Peer review
This study has investigated in experimental animals the effects of probiotics 
on rotavirus-induced diarrhea using Lactobacillus strain. They have used killed 
and live Lactobacillus strain in animals in which diarrhea was induced by rota-
viruses. The findings are supportive of early observations of similar nature and 
are of clinical significance. 
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